help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia Pedrero, J. M.
Right arrow Articles by Rodrigo, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia Pedrero, J. M.
Right arrow Articles by Rodrigo, J. P.
(American Journal of Pathology. 2004;164:73-79.)
© 2004 American Society for Investigative Pathology

Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status

Juana Maria Garcia Pedrero*, M. Pilar Fernandez{dagger}, Reginald O. Morgan{dagger}, Agustin Herrero Zapatero{ddagger}, Maria Victoria Gonzalez*, Carlos Suarez Nieto*§ and Juan Pablo Rodrigo*§

From the Instituto Universitario de Oncologia del Principado de Asturias,* Oviedo; the Departamento de Bioquimica y Biologia Molecular,{dagger} Universidad de Oviedo, Oviedo; and the Servicio Anatomia Patologica{ddagger} y de Otorrinolaringologia,§ Hospital Central de Asturias, Oviedo, Spain

Annexin A1 (ANXA1) protein expression was evaluated by Western blot in a series of 32 head and neck squamous cell carcinomas (HNSCCs) in a search for molecular alterations that could serve as useful diagnostic/prognostic markers. ANXA1 down-regulation was observed in 24 cases (75%) compared with patient-matched normal epithelium. In relation to clinicopathological variables, ANXA1 down-regulation was significantly associated with advanced T stages (P = 0.029), locoregional lymph node metastases (P = 0.038), advanced disease stage (P = 0.006), hypopharyngeal localization (P = 0.038), and poor histological differentiation (P = 0.005). ANXA1 expression was also analyzed by immunohistochemistry in paraffin-embedded sections from 22 of 32 HNSCCs and 8 premalignant lesions. All dysplastic tissues showed significantly reduced ANXA1 expression compared to a strong positive signal observed in adjacent normal epithelia (except basal and suprabasal cells). A close association was observed between ANXA1 expression and the histological grade in HNSCC. Well-differentiated tumors presented a positive ANXA1 signal in highly keratinized areas whereas moderately and poorly differentiated tumors exhibited very weak or negative staining. Our findings clearly identify ANXA1 as an effective differentiation marker for the histopathological grading of HNSCCs and for the detection of epithelial dysplasia.





This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al.
Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
A. M. Mlynarek, R. L. Balys, J. Su, M. P. Hier, M. J. Black, and M. A. Alaoui-Jamali
A Cell Proteomic Approach for the Detection of Secretable Biomarkers of Invasiveness in Oral Squamous Cell Carcinoma
Arch Otolaryngol Head Neck Surg, September 1, 2007; 133(9): 910 - 918.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. H. K. Lim and S. Pervaiz
Annexin 1: the new face of an old molecule
FASEB J, April 1, 2007; 21(4): 968 - 975.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Wang, T.-T. Wu, E. Resetkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, et al.
Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome
Clin. Cancer Res., August 1, 2006; 12(15): 4598 - 4604.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Wallqvist, J. Connelly, E. A. Sausville, D. G. Covell, and A. Monks
Differential Gene Expression as a Potential Classifier of 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole-Sensitive and -Insensitive Cell Lines
Mol. Pharmacol., March 1, 2006; 69(3): 737 - 748.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.